πŸ‡ΊπŸ‡Έ FDA
Patent

US 12168057

IRAK degraders and uses thereof

granted A61KA61K31/404A61K31/422

Quick answer

US patent 12168057 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kymera Therapeutics, Inc.
Grant date
Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/404, A61K31/422, A61K31/427, A61K31/4439